Adequate use of modern treatment opportunities for uterine fibroid
https://doi.org/10.21518/2079-701X-2013-8-84-87
Abstract
The article tells about the results of a study to evaluate effectiveness of progesterone receptor antagonist Ginestril (mifepristone) in the treatment of uterine fibroid.
About the Authors
A. L. Tikhomirov
Moscow State University of Medicine and Dentistry named after A.I. Evdokimov
Russian Federation
Russian Federation
V. V. Kazenashev
Moscow State University of Medicine and Dentistry named after A.I. Evdokimov
Russian Federation
Russian Federation
T. A. Yudina
Medical holding "SM-Klinika", Moscow
Russian Federation
Russian Federation
E. P. Mavromatis
Medical holding "SM-Klinika", Moscow
Russian Federation
Russian Federation
References
1. Rein M. S., A. J. Friedman et al. Cytogenetic abnormalities in uterine leiomyomata // Obstet. Gynecol. 1991. №77 (6). Р. 923–926.
2. Tiltman A. J. Smooth muscle neoplasms of the uterus//Curr. Opin. Obstet. Gynecol. 1991. №9 (1). Р. 48–51.
3. Kawaguchi K. S. Fujii et al. Mitotic activity in uterine leiomyomas during the menstrual cycle // Am. J. Obstet. Gynecol. 1989. № 160 (3). Р. 637–641.
4. Fujimoto J., Ichigo S. et al. Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine endometrial cancers // Cancer. Lett. 1998. №130 (1–2). Р. 115–120.
5. Friedman A. J. Clinical experience in the treatment of fibroids with leuprolide and other GnRH agonists //Obstet. Gynecol. Surv. 1989. №44 (5). Р. 311–313.
6. Hyder S. M., Huang J. C. et al. Regulation of vascular endothelial growth factor expression by estrogens and progestins // Environ. Health Perspec. 2000. T. 108. Suppl. 5. Р. 785–790.
7. Shimomura Y., Matsuo H. et al. Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma // J. Clin. Endocrinol. Metab. 1998. №83 (6). Р. 2192–2198.
8. Тихомиров А. Л. Миома, патогенетическое обоснование органосохраняющего лечения: монография. М., 2013.
9. Kelly R. W., King A. E., Critchley H. O. D. Inflammatory mediators and endometrial function – focus on the perivascular cell // Reprod. Immunol. 2002. №57. Р. 81–93.
10. Baird D. T., Brown A., Critchley H. O. D. et al. Effect of long-term treatment with low-dose mifepristone on the endometrium // Hum. Reprod. 2003. №18. Р. 61–68.
11. Eisinger S. H., Bonfiglio T., Fiscella K., Meldrum S., Guzick D. S. Twelve-month safety and efficacy of low-dose mifepristone for uterine myomas // J. Minim. Invasive Gynecol. 2005. №12. Р. 227–233.
Review
For citations:
Tikhomirov AL, Kazenashev VV, Yudina TA, Mavromatis EP. Adequate use of modern treatment opportunities for uterine fibroid. Meditsinskiy sovet = Medical Council. 2013;(8):84-87. (In Russ.) https://doi.org/10.21518/2079-701X-2013-8-84-87
Views:
465
Email this article 